OPTN OptiNose Inc

Price (delayed)

$1.25

Market cap

$140.39M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.38

Enterprise value

$203.36M

Optinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. Optinose has offices in the U.S. ...

Highlights
OPTN's EPS has soared by 59% YoY and by 21% from the previous quarter
OptiNose's net income has increased by 46% YoY and by 12% from the previous quarter
The quick ratio is up by 10% year-on-year but it has declined by 5% since the previous quarter
The equity has declined by 11% since the previous quarter and by 6% year-on-year
The gross profit has contracted by 10% YoY

Key stats

What are the main financial stats of OPTN
Market
Shares outstanding
112.31M
Market cap
$140.39M
Enterprise value
$203.36M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
1.95
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.83
Earnings
Revenue
$71.98M
EBIT
-$21.8M
EBITDA
-$21.39M
Free cash flow
-$45.38M
Per share
EPS
-$0.38
Free cash flow per share
-$0.4
Book value per share
-$0.69
Revenue per share
$0.64
TBVPS
$0.9
Balance sheet
Total assets
$101.41M
Total liabilities
$179.02M
Debt
$129.81M
Equity
-$77.62M
Working capital
-$65.36M
Liquidity
Debt to equity
-1.67
Current ratio
0.6
Quick ratio
0.54
Net debt/EBITDA
-2.94
Margins
EBITDA margin
-29.7%
Gross margin
86.8%
Net margin
-56.6%
Operating margin
-39.7%
Efficiency
Return on assets
-34.9%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
N/A
Return on sales
-30.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

OPTN stock price

How has the OptiNose stock price performed over time
Intraday
1.63%
1 week
2.04%
1 month
2.46%
1 year
-28.57%
YTD
-32.43%
QTD
1.63%

Financial performance

How have OptiNose's revenue and profit performed over time
Revenue
$71.98M
Gross profit
$62.5M
Operating income
-$28.59M
Net income
-$40.72M
Gross margin
86.8%
Net margin
-56.6%
The operating income has surged by 52% year-on-year and by 24% since the previous quarter
The operating margin has grown by 48% year-on-year and by 24% since the previous quarter
OptiNose's net income has increased by 46% YoY and by 12% from the previous quarter
OPTN's net margin is up by 41% YoY and by 12% QoQ

Growth

What is OptiNose's growth rate over time

Valuation

What is OptiNose stock price valuation
P/E
N/A
P/B
N/A
P/S
1.95
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.83
OPTN's EPS has soared by 59% YoY and by 21% from the previous quarter
The equity has declined by 11% since the previous quarter and by 6% year-on-year
OPTN's price to sales (P/S) is 77% less than its 5-year quarterly average of 8.3 and 13% less than its last 4 quarters average of 2.2
OptiNose's revenue has decreased by 8% YoY

Efficiency

How efficient is OptiNose business performance
OPTN's ROS has soared by 60% YoY and by 22% from the previous quarter
The ROA has grown by 39% YoY and by 11% from the previous quarter

Dividends

What is OPTN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for OPTN.

Financial health

How did OptiNose financials performed over time
OptiNose's total assets is 43% less than its total liabilities
The quick ratio is up by 10% year-on-year but it has declined by 5% since the previous quarter
OPTN's current ratio is up by 5% year-on-year but it is down by 4.8% since the previous quarter
The equity has declined by 11% since the previous quarter and by 6% year-on-year
OptiNose's debt to equity has increased by 10% QoQ and by 4% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.